Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"REACT-FM-EXT": Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study

NCT05149222 is registered in ClinicalTrials.gov with Swing Therapeutics, Inc. as lead sponsor.

NCT NCT05149222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05149222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"REACT-FM-EXT": Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study
Lead sponsor
Swing Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2021
Completion date
April 14, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia